1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 3:Statistical results of the paired t test for the CBF, OEF, and CMRO2 in the 4 patient subgroups
Contralateral Stenosis CBF (mL/100 g/min) OEF (%) CMRO2 (μmol/100 g/min) Group 1 51.9 ± 9.5 50.7 ± 11.2 38.5 ± 3.9 40.6 ± 4.2 153.2 ± 24.0 155.5 ± 22.9 T 0.796 4.027 0.377 P .442 .002 .713 Group 2 54.6 ± 5.9 47.9 ± 9.8 38.4 ± 1.9 42.6 ± 3.8 150.3 ± 28.5 149.4 ± 46.1 T 4.146 4.690 0.132 P .002 .001 .898 Group 3 54.0 ± 10.3 37.2 ± 9.7 37.1 ± 2.9 44.5 ± 3.9 154.0 ± 43.4 125.3 ± 35.3 T 6.295 6.128 2.926 P <.001 <.001 .010 Group 4 55.3 ± 9.5 40.8 ± 11.8 38.3 ± 4.1 43.9 ± 3.5 161.2 ± 47.4 135.0 ± 41.3 T 5.898 4.626 2.647 P <.001 <.001 .018